Jim Longley Joins Outcomes4Me as Chief Revenue Officer
News related to:Outcomes4Me Inc · 2 min read
Jim Longley, a veteran in the health technology sector, has joined Outcomes4Me Inc. as Chief Revenue Officer, aiming to accelerate the company's growth and support its mission of empowering patients with cancer.
Longley brings extensive experience in scaling revenue and driving commercial strategy. Prior to joining Outcomes4Me, he served as the Senior Vice President: AI Partnerships at OpenEvidence, where he focused on building partnerships at the intersection of AI and healthcare. His previous roles include Senior Vice President and Head of Commercial at GoodRx and Vice President for Business Development and Product Innovation at Doximity.
At Outcomes4Me, Longley will lead the commercial team, leveraging his expertise to drive further value for patients, providers, pharmaceutical companies, and diagnostic firms.
Maya R. Said, Sc.D., Founder and CEO of Outcomes4Me, expressed enthusiasm about Longley's appointment.
In the past quarter, Outcomes4Me has achieved significant milestones. The company was honored on the Inc. 5000 list of fastest-growing private companies for the second year in a row, experiencing 395% three-year growth. Dr. Maya R. Said was also recognized on the 2026 Fierce50 list by the editorial teams from Fierce Pharma, Fierce Biotech, and Fierce Healthcare, highlighting leaders driving innovation in healthcare. Outcomes4Me was also nominated for the prestigious Prix Galien USA program.
The company's clinical team integrated 10 National Comprehensive Cancer Network® (NCCN®) updates into the Outcomes4Me platform, covering bladder cancer, breast cancer, kidney cancer, non-small cell lung cancer, and prostate cancer. These updates ensure patients using the Outcomes4Me platform have access to the latest recommended treatment options, according to the NCCN®.
Additionally, Outcomes4Me's poster "Are We Listening to Every Patient? Digital Tools, Patient-Reported Outcomes and Disparities in Breast Cancer" was selected for a spotlight session at the upcoming San Antonio Breast Cancer Symposium, scheduled for December 10, 2026.
Outcomes4Me is the leading direct-to-patient platform for cancer care, supporting more than 400,000 patients from diagnosis through every stage of treatment. Its AI-driven platform integrates clinical guidelines, genomics, clinical trial matching, and symptom tracking to help patients make informed, confident decisions about their care, without fees or gatekeepers. With 9 of the top 10 oncology pharmaceutical companies as customers, Outcomes4Me generates unique, at-scale proprietary datasets and insights that accelerate innovation in cancer care, helping bring better treatments to more patients, faster.